Quels sont les bienfaits de la yohimbine ?

↑1 Millan, M. J., et al. « Agonist and Antagonist Actions of Yohimbine as Compared to Fluparoxan at Alpha(2)-Adrenergic Receptors (AR)s, Serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and Dopamine D(2) and D(3) Receptors. Significance for the Modulation of Frontocortical Monoaminergic Transmission and Depressive States ». Synapse (New York, N.Y.), vol. 35, no 2, février 2000, p. 79‑95. PubMed, doi:10.1002/(SICI)1098-2396(200002)35:23.0.CO;2-X. https://www.ncbi.nlm.nih.gov/pubmed/10611634 ↑2 Ernst, E., et M. H. Pittler. « Yohimbine for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials ». The Journal of Urology, vol. 159, no 2, février 1998, p. 433‑36. PubMed, doi:10.1016/s0022-5347(01)63942-9. https://www.ncbi.nlm.nih.gov/pubmed/9649257 ↑3 Susset, J. G., et al. « Effect of Yohimbine Hydrochloride on Erectile Impotence: A Double-Blind Study ». The Journal of Urology, vol. 141, no 6, juin 1989, p. 1360‑63. PubMed, doi:10.1016/s0022-5347(17)41308-5. https://www.ncbi.nlm.nih.gov/pubmed/2657105 ↑4 Akhondzadeh, Shahin, et al. « Efficacy and Safety of Oral Combination of Yohimbine and L-Arginine (SX) for the Treatment of Erectile Dysfunction: A Multicenter, Randomized, Double Blind, Placebo-Controlled Clinical Trial ». Iranian Journal of Psychiatry, vol. 5, no 1, 2010, p. 1‑3. https://www.ncbi.nlm.nih.gov/pubmed/22952481 ↑5 Saad, Muhammed A., et al. « Potential Effects of Yohimbine and Sildenafil on Erectile Dysfunction in Rats ». European Journal of Pharmacology, vol. 700, no 1‑3, janvier 2013, p. 127‑33. PubMed, doi:10.1016/j.ejphar.2012.12.020. https://www.ncbi.nlm.nih.gov/pubmed/23274729 ↑6 Zahorska-Markiewicz, B., et al. « Adrenergic Control of Lipolysis and Metabolic Responses in Obesity ». Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme, vol. 18, no 10, octobre 1986, p. 693‑97. PubMed, doi:10.1055/s-2007-1012409. https://www.ncbi.nlm.nih.gov/pubmed/2877928 ↑7 Holmes, Andrew, et Gregory J. Quirk. « Pharmacological Facilitation of Fear Extinction and the Search for Adjunct Treatments for Anxiety Disorders–the Case of Yohimbine ». Trends in Pharmacological Sciences, vol. 31, no 1, janvier 2010, p. 2‑7. PubMed, doi:10.1016/j.tips.2009.10.003. https://www.ncbi.nlm.nih.gov/pubmed/20036429 ↑8 Smits, Jasper A. J., et al. « Yohimbine Enhancement of Exposure Therapy for Social Anxiety Disorder: A Randomized Controlled Trial ». Biological Psychiatry, vol. 75, no 11, juin 2014, p. 840‑46. PubMed, doi:10.1016/j.biopsych.2013.10.008. https://www.ncbi.nlm.nih.gov/pubmed/24237691 ↑9 O’Carroll, R. E., et al. « Stimulation of the Noradrenergic System Enhances and Blockade Reduces Memory for Emotional Material in Man ». Psychological Medicine, vol. 29, no 5, septembre 1999, p. 1083‑88. PubMed, doi:10.1017/s0033291799008703. https://www.ncbi.nlm.nih.gov/pubmed/10576300 ↑10, ↑11 Undas, A. « Fibrin Clot Properties and Their Modulation in Thrombotic Disorders ». Thrombosis and Haemostasis, vol. 112, no 1, juillet 2014, p. 32‑42. PubMed, doi:10.1160/TH14-01-0032. https://www.ncbi.nlm.nih.gov/pubmed/24671700 ↑12 Bagheri, H., et al. « Evidence for Activation of Both Adrenergic and Cholinergic Nervous Pathways by Yohimbine, an Alpha 2-Adrenoceptor Antagonist ». Fundamental & Clinical Pharmacology, vol. 9, no 3, 1995, p. 248‑54. PubMed, doi:10.1111/j.1472-8206.1995.tb00292.x. https://www.ncbi.nlm.nih.gov/pubmed/7557820 ↑13 Chatelut, E., et al. « Yohimbine increases human salivary secretion. » British Journal of Clinical Pharmacology, vol. 28, no 3, septembre 1989, p. 366‑68. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1379958/ ↑14 Bagheri, H., et al. « A Comparative Study of the Effects of Yohimbine and Anetholtrithione on Salivary Secretion in Depressed Patients Treated with Psychotropic Drugs ». European Journal of Clinical Pharmacology, vol. 52, no 5, 1997, p. 339‑42. PubMed, doi:10.1007/s002280050298. https://www.ncbi.nlm.nih.gov/pubmed/9272401 ↑15 Anderson, Colin, et al. « Case Study: Two Fatal Case Reports of Acute Yohimbine Intoxication ». Journal of Analytical Toxicology, vol. 37, no 8, octobre 2013, p. 611‑14. PubMed, doi:10.1093/jat/bkt057. https://www.ncbi.nlm.nih.gov/pubmed/23846025 ↑16 Sørensen, Janina Maria. « Herb-Drug, Food-Drug, Nutrient-Drug, and Drug-Drug Interactions: Mechanisms Involved and Their Medical Implications ». Journal of Alternative and Complementary Medicine (New York, N.Y.), vol. 8, no 3, juin 2002, p. 293‑308. PubMed, doi:10.1089/10755530260127989. https://www.ncbi.nlm.nih.gov/pubmed/12165187 ↑17 McCarty, Mark F. « Pre-Exercise Administration of Yohimbine May Enhance the Efficacy of Exercise Training as a Fat Loss Strategy by Boosting Lipolysis ». Medical Hypotheses, vol. 58, no 6, juin 2002, p. 491‑95. PubMed, doi:10.1054/mehy.2001.1459. https://www.ncbi.nlm.nih.gov/pubmed/12323115